跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACH-PREGABALIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ACH-PREGABALIN
Authorized
STANDARD
ACH-PREGABALIN
Accord Healthcare Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7030452e56b91f41
Company
Accord Healthcare Inc
Type
Standard
Approval Details
Approval Id
7030452e56b91f41
Drug Approval Canada Name
ACH-PREGABALIN
Product Name
ACH-PREGABALIN
Status
Marketed
Status Date
2021-05-27
Original Market Date
2021-05-27
Din
02449838
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:12.92
Atc Original
N02BF02 PREGABALIN
Atc Name
n 02 bf 02
Aig Number
0151121001
Company Name
Accord Healthcare Inc
Company Address
3535 Boulevard St-Charles, Suite 704, Kirkland, Quebec, Canada, H9H 5B9
Company Detail Path
/organization/accord-healthcare-inc
Company Information
Pharmaceutical Company Name
Accord Healthcare Inc
Country Name
Canada
Province Name
Quebec
City Name
kirkland,quebec,country_ca
Address
704-3535 boul Saint-Charles
Active Ingredients
PREGABALIN
25 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7030452e56b91f41
Type
Standard
Back to Health Canada Approvals